COVID-19 Vaccine Hesitancy among Adults in India: A Systematic Review and Meta-analysis.

IF 0.9 4区 医学 Q4 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
Indian journal of public health Pub Date : 2024-10-01 Epub Date: 2024-12-13 DOI:10.4103/ijph.ijph_939_23
M D Sangeetha, P K Sreenath Menon, Bhalangki Kupar Kharmawphlang, Darshan Hoysanahalli Shivashankarappa, Sharath Burugina Nagaraja
{"title":"COVID-19 Vaccine Hesitancy among Adults in India: A Systematic Review and Meta-analysis.","authors":"M D Sangeetha, P K Sreenath Menon, Bhalangki Kupar Kharmawphlang, Darshan Hoysanahalli Shivashankarappa, Sharath Burugina Nagaraja","doi":"10.4103/ijph.ijph_939_23","DOIUrl":null,"url":null,"abstract":"<p><strong>Summary: </strong>The global health crisis triggered by the SARS-CoV-2 in 2019, known as the COVID-19 pandemic, prompted vaccination drives worldwide, including in India, to address the crisis. However, vaccine hesitancy remains a significant challenge to achieving vaccination goals. Hence, we conducted a systematic review and meta-analysis during 2021-2023 to estimate the prevalence of COVID-19 vaccine hesitancy among adults in India and identify associated factors. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines were followed. Quality assessment was performed using the Joanna Briggs Institute checklist. Pooled prevalence estimates were calculated using a random-effects model. A total of 265 articles were identified, of which 21 full-text articles were included in the review. The pooled estimated prevalence of COVID-19 vaccine hesitancy among adults in India was found to be 28% (95% confidence interval: 27-29). Subgroup analysis revealed variations in hesitancy rates across different states, with higher rates observed in Jammu and Kashmir (44%), West Bengal (49%), and Maharashtra (39%). Gender-based analysis indicated higher hesitancy among males (36%) compared to females (26%). Among different study populations, medical students showed the lowest hesitancy rate (13%), whereas the general population exhibited the highest (34%). The findings suggest that vaccine hesitancy remains a significant concern in India, with one in four adults expressing hesitancy toward COVID-19 vaccination. Hesitancy rates vary across states, genders, and study populations. Addressing the factors contributing to hesitancy, such as safety concerns, lack of evidence, and misinformation, is crucial to enhance vaccine acceptance.</p>","PeriodicalId":13298,"journal":{"name":"Indian journal of public health","volume":"68 4","pages":"534-540"},"PeriodicalIF":0.9000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indian journal of public health","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4103/ijph.ijph_939_23","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/12/13 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0

Abstract

Summary: The global health crisis triggered by the SARS-CoV-2 in 2019, known as the COVID-19 pandemic, prompted vaccination drives worldwide, including in India, to address the crisis. However, vaccine hesitancy remains a significant challenge to achieving vaccination goals. Hence, we conducted a systematic review and meta-analysis during 2021-2023 to estimate the prevalence of COVID-19 vaccine hesitancy among adults in India and identify associated factors. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines were followed. Quality assessment was performed using the Joanna Briggs Institute checklist. Pooled prevalence estimates were calculated using a random-effects model. A total of 265 articles were identified, of which 21 full-text articles were included in the review. The pooled estimated prevalence of COVID-19 vaccine hesitancy among adults in India was found to be 28% (95% confidence interval: 27-29). Subgroup analysis revealed variations in hesitancy rates across different states, with higher rates observed in Jammu and Kashmir (44%), West Bengal (49%), and Maharashtra (39%). Gender-based analysis indicated higher hesitancy among males (36%) compared to females (26%). Among different study populations, medical students showed the lowest hesitancy rate (13%), whereas the general population exhibited the highest (34%). The findings suggest that vaccine hesitancy remains a significant concern in India, with one in four adults expressing hesitancy toward COVID-19 vaccination. Hesitancy rates vary across states, genders, and study populations. Addressing the factors contributing to hesitancy, such as safety concerns, lack of evidence, and misinformation, is crucial to enhance vaccine acceptance.

COVID-19 印度成年人对疫苗的犹豫不决:系统回顾与元分析》。
摘要:2019年SARS-CoV-2引发的全球卫生危机,即COVID-19大流行,促使包括印度在内的世界各地开展了疫苗接种活动,以应对危机。然而,疫苗犹豫仍然是实现疫苗接种目标的重大挑战。因此,我们在2021-2023年期间进行了系统回顾和荟萃分析,以估计印度成年人中COVID-19疫苗犹豫的患病率并确定相关因素。遵循系统评价和荟萃分析指南的首选报告项目。使用乔安娜布里格斯研究所的检查表进行质量评估。使用随机效应模型计算合并患病率估计值。共识别265篇文章,其中21篇全文文章纳入综述。发现印度成年人中COVID-19疫苗犹豫的总估计患病率为28%(95%置信区间:27-29)。亚组分析显示,不同邦的犹豫率存在差异,查谟和克什米尔(44%)、西孟加拉邦(49%)和马哈拉施特拉邦(39%)的犹豫率较高。基于性别的分析表明,男性(36%)比女性(26%)更犹豫不决。在不同的研究人群中,医学生的犹豫率最低(13%),而普通人群的犹豫率最高(34%)。研究结果表明,疫苗犹豫在印度仍然是一个重大问题,四分之一的成年人表示对COVID-19疫苗接种犹豫不决。犹豫率因州、性别和研究人群而异。解决导致犹豫的因素,如安全问题、缺乏证据和错误信息,对于提高疫苗接受度至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Indian journal of public health
Indian journal of public health PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH-
CiteScore
2.40
自引率
0.00%
发文量
92
审稿时长
21 weeks
期刊介绍: Indian Journal of Public Health is a peer-reviewed international journal published Quarterly by the Indian Public Health Association. It is indexed / abstracted by the major international indexing systems like Index Medicus/MEDLINE, SCOPUS, PUBMED, etc. The journal allows free access (Open Access) to its contents and permits authors to self-archive final accepted version of the articles. The Indian Journal of Public Health publishes articles of authors from India and abroad with special emphasis on original research findings that are relevant for developing country perspectives including India. The journal considers publication of articles as original article, review article, special article, brief research article, CME / Education forum, commentary, letters to editor, case series reports, etc. The journal covers population based studies, impact assessment, monitoring and evaluation, systematic review, meta-analysis, clinic-social studies etc., related to any domain and discipline of public health, specially relevant to national priorities, including ethical and social issues. Articles aligned with national health issues and policy implications are prefered.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信